EVALUATION OF THE ANTIMICROBIAL ACTIVITY OF THE BACTERIAL PROBIOTIC BACILLUS SUBTILIS-534


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To refine the phylogenetic position of and to determine the antimicrobial spectrum and nature of antibiotic activity of the bacterial probiotic Bacillus subtilis-534. Materials and methods. PCR was used to investigate the 16S rRNA gene of strain 534. DNA sequencing was performed using an automatic 3500 Genetic Analyzer and compared with other sequences in the GenBank and Ribosomal Database Project. Antimicrobial activity against 17 test strains was determined in the submerged culture of strain 534 by the agar-diffusion method. The antibiotic was isolated from culture liquid by sorption on an Amberlite XAD-2 resin, by desorption of a mixture of n-butanol-acetone-water, followed by evaporation and dissolution in 60% aqueous ethanol, by injection of the solution into a Kieselgel 60 silica gel column and by stepwise elution with chloroform-methanol solvents. The active fractions were examined by a thin-layer chromatography bioautography method. The UV-absorption spectrum was determined on a UV-1601 PC spectrophotometer. Results. Analysis of DNA sequence of the 16S rRNA gene deposited in the international GenBank under number KU051696 has confirmed that strain 534 belongs to the species Bacillus subtilis. Cultured in vitro, strain 534 suppresses the growth of a number of the strains of Staphylococcus aureus (including MRSA), S. epidermidis, S. haemolyticus, S. hominis, Bacillus pumilis, Micrococcus luteus, Klebsiella рneumoniae, Candida sp., Aspergillus niger, and Saccharomyces cerevisiae. B. subtilis-534 was ascertained to form at least three antibiotics. Conclusion. The bacterial probiotic Bacillus subtilis-534 is the basis of Sporobacterin, shows antibacterial and antifungal activity during submerged cultivation. A chemical assay has indicated the formation of at least three antibiotics, one of which belongs to polyenes, namely: trienes.

Full Text

Restricted Access

About the authors

N. I GABRIELYAN

Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Ministry of Health of Russia

Email: labgso@mail.ru

E. M GORSKAYA

Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Ministry of Health of Russia

Email: emg168@mail.ru

T. V KRUPENIO

Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Ministry of Health of Russia

Email: ypsa89@mail.ru

V. A ZENKOVA

G. F. Gauze Research Institute for Searching for New Antibiotics

Email: ovefr@yandex.ru

T. A EFIMENKO

G. F. Gauze Research Institute for Searching for New Antibiotics

Email: efimen@inbox.ru

I. A MALANICHEVA

G. F. Gauze Research Institute for Searching for New Antibiotics

Email: malanicheva.irina@yandex.ru

I. G SUMARUKOVA

G. F. Gauze Research Institute for Searching for New Antibiotics

Email: noks59@yandex.ru

O. V EFREMENKOVA

G. F. Gauze Research Institute for Searching for New Antibiotics

Email: ovefr@yandex.ru

V. F EVLASHKINA

Research Center for Examination of Medical Products, Ministry of Health of Russia

Email: evlashkina@expmed.ru

D. S DAVYDOV

Research Center for Examination of Medical Products, Ministry of Health of Russia

Email: davydov@expmed.ru

References

  1. Johnson B., Anker H., Meleney F. Bacitracin: a new antibiotic produced by a member of the B. subtilis group. Science 1945; 102: 376-377.
  2. Suzuki M., Yamada K., Nagao M., Aoki EL., Matsumoto M., Hirayama T., Yamamoto H., Hiramatsu R., Ichiyama S., Iinuma Y. Antimicrobial ointments and methicillin-resistant Staphylococcus aureus USA300. Emerg. Infect. Dis. 2011; 17(10): 1917-1920.
  3. Fickeis P. Antibiotic compounds from Bacillus: why are they so amazing? Am. J. Biochem. and Biotech. 2012; 8(1): 40-46.
  4. Габриэлян Н.И., Сускова В.С., Сусков С.И., Темнова В.В., Вологодская Н.Л. Изучение влияния пробиотика споробактерина на функциональное состояние фагоцитарной системы. Бюллетень экспериментальной биологии и медицины 2012; 153(5): 653-656.
  5. Габриэлян Н.И., Давыдов Д.С., Горская Е.М., Спирина Т. С., Осипова И.Г. Антагонизм in vitro споробактерина в отношении нозокомиальных штаммов микробов. Вестник трансплантологии и искусственных органов 2008; 6; 12-18.
  6. Казаков Э.Н., Габриэлян Н.И., Сенченко О.Р., Петраков К.В., Арефьева Л.И., Воронин Е.М. К вопросу о профилактике инфекционных осложнений после кардиохирургических вмешательств в условиях искусственного кровообращения. Российский медицинский журнал 2013; 2: 13-16.
  7. Третьяков А.А., Стадников А.А., Валышев А.В. Клинико-экспериментальное обоснование применения споробактерина в комплексной терапии при механической желтухе. Анналы травматологии и ортопедии 2001; 2: 42-48.
  8. Сорокина В.О., Минасов Б.Ш., Попова О.В., Попов О.С. Применение споробактерина в лечении пациентов с ожоговыми ранами. Медицинский вестник Башкортостана 2013; 8(6): 106-108.
  9. Ветлугина Л.А., Никитина Е.Т. Противогрибковые полиеновые антибиотики. Алма-Ата: Наука, 1980. 247 с.
  10. Nishikiori T., Masuma R., Oiwa R., Katagiri M., Awaya J., Iwai Y., Omura S. Aurantinin, a new antibiotic of bacterial origin. J. Antib. 1978; 31(6): 525-532.
  11. Neseman G., Prave P., Sukatsch D., Vertesy L. Ein Polyen-Antibiotikum aus Bakterien. Naturwissenschaften 1972; 59: 81-82.
  12. Abriouel H., Franz C.M.A.P., Ben Omar N., Galvez A. Diversity and applications of Bacillus bacteriocins. FEMS Microbiol. Rev. 2011; 35: 201-232.
  13. Raaijmakers J.M., De Bruijn I., Nybroe O., Ongena M. Natural functions of lipopeptides from Bacillus and Pseudomonas: more than surfactants andantibiotics. FEMS Microbiol Rev. 2010; 34(6): 1037-1062.
  14. Rea M.C., Ross R.P., Cotter P.D., Hill C. Classification of bacteriocins from gram-positive bacteria. In: Drider D., Rebuffat S. (eds.). Prokaryotic Antimicrobial Peptides: From Genes to Applications. New York: Springer-Verlag, 2011; Chapter 3: 29-53.
  15. Shahcheraghi S.H., Ayatollahi J., Lotfi M. Applications of Bacillus subtilis as an important bacterium in medical sciences and human life. Trop. J. Med. Res. 2015; 18: 1-4.
  16. Егоров Е.С., Баранова И.Н. Бактериоцины: Образование, свойства, применение. Антибиотики и химиотерапия 1999; 6: 33-40.
  17. Маланичева И.А., Козлов Д.Г., Ефименко Т.А., Зенкова В.А., Катруха Г.С., Резникова М.И., Королев А.М., Борщевская Л.Н., Тарасова О.Д., Синеокий С.П., Ефременкова О.В. Новые антибиотики, образуемые штаммами Bacillus subtilis. Микробиология 2014; 83(4): 445-450.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies